Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,021,584
-$2,461,016 QoQ
Shares Held
60,195
-36.1% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#97
of 301 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$4,610,796
CallShares
34,600
PutValue
$11,993,400
PutShares
90,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names. ABVX ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in ABVX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,610,796 | 34,600 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $11,993,400 | 90,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $8,021,584 | 60,195 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,529,410 | 76,600 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $4,988,480 | 44,800 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $10,482,600 | 94,141 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $29,479,302 | 218,600 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $57,078,321 | 423,257 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $30,652,541 | 227,300 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $5,756,389 | 67,802 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||